Search - tctmd.com

Displaying 581 - 600 of 704

Sort: Relevancy | Date

News Industry News

Tryton Medical Announces Publication of Post Hoc Analysis of Randomized Clinical Trial in Treatment of Bifurcation Lesions using Tryton Side Branch Stent

September 30, 2015

News Industry News

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

September 29, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Conference News ESC 2015

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

L.A. McKeown

August 30, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Industry News

Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients

July 28, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Daily News

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

L.A. McKeown

July 27, 2015

Advertisement

Tryton Medical Announces Publication of Post Hoc Analysis of Randomized Clinical Trial in Treatment of Bifurcation Lesions using Tryton Side Branch Stent

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Study Supports Multiarterial CABG for Multivessel CAD

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients

Lilly Provides Update on Evacetrapib Phase 3 Trial

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content